Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

122 Press Releases
DateTitleCompany
27 Aug 15 OVER 550 WOMEN’S LIVES TRANSFORMED TO-DATE WITH ACTION ON FISTULA Astellas Pharma EMEA
05 Aug 15 #pass4prostate Challenge Raises Prostate Cancer Awareness and Research Funds Astellas Pharma,
Published by
PR Newswire
31 Jul 15 Astellas Establishes New Real World Informatics and Analytics Function Astellas,
Published by
PharmiWeb.com
31 Jul 15 Astellas Salutes Military Families at Fisher House San Antonio Event Astellas,
Published by
PharmiWeb.com
31 Jul 15 Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections Astellas,
Published by
PharmiWeb.com
23 Jul 15 Astellas Initiates Collaborative Research with National Institute of Advanced Industrial Science andTechnology by Utilizing Highly Advanced IT Drug - Discovery Technologies Astellas,
Published by
PharmiWeb.com
22 Jul 15 Cell therapy using human iPSC - derived renal progenitors ameliorates acute kidney injury in mice” published in “Stem Cells Translational Medicine” on line Astellas,
Published by
PharmiWeb.com
16 Jul 15 The Netherlands Decorates Masafumi Nogimori, Representative Director and Chairman of Astellas with Officer in the Order of Oranje - Nassau Royal Decoration Astellas Pharma,
Published by
PharmiWeb.com
13 Jul 15 Notice of Completion of Acquisition of Own Shares Astellas Pharma,
Published by
PharmiWeb.com
17 Jun 15 Astellas And Medivation Announce Enrollment Of The First Patients In Advanced Prostate Cancer Outcomes Registry Astellas,
Published by
PR Newswire
15 Jun 15 Results of Additional Analysis of Data from Japanese Clinical Trial of Anti - TNF - alpha Antibody Certolizumab Pegol Announced at 2015 EULAR Annual European Congress of Rheumatology Astellas,
Published by
PharmiWeb.com
15 Jun 15 ASTELLAS ANNOUNCES PRELIMINARY PHASE 1/2 SAFETY, TOLERABILITY AND EFFICACY DATA FOR ASP2215 IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA ASTELLAS,
Published by
PharmiWeb.com
09 Jun 15 Tarsis Lopez joins Astellas Corporate Affairs Astellas,
Published by
PR Newswire
01 Jun 15 New Enzalutamide Data In Triple-negative Breast Cancer Presented At The 2015 American Society Of Clinical Oncology Annual Meeting Astellas Pharma Inc.,
Published by
PR Newswire
20 May 15 Astellas Pharma EMEA Celebrates Its 10th Anniversary Astellas Pharma,
Published by
Business Wire
20 May 15 ASTELLAS PHARMA EMEA CELEBRATES ITS 10TH ANNIVERSARY Astellas Pharma EMEA
19 May 15 DIFICLIRTM (fidaxomicin) significantly reduces recurrence and all-cause mortality when used first-line in all patients with Clostridium difficile infection (CDI) Astellas,
Published by
PharmiWeb.com
17 May 15 Mirabegron As Add-On Treatment To Solifenacin Therapy Demonstrated Superior Results To Solifenacin Monotherapy In BESIDE Trial Astellas Pharma US, Inc.,
Published by
PR Newswire
14 May 15 Astellas Announces New Data in Advanced Prostate and Breast Cancers Acute Myeloid Leukemia and Lung and Renal Cancers To Be Presented at 2015 ASCO Annual Meeting Astellas,
Published by
PR Newswire
05 May 15 Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting Astellas,
Published by
PR Newswire
06 Apr 15 Astellas Appoints Shontelle Dodson to Lead Medical Excellence Function ASTELLAS PHARMA INC.,
Published by
PR Newswire
03 Apr 15 MD Anderson Astellas Pharma Sign Option Agreement for Monoclonal Antibody Drug Targeting Acute Myeloid Leukemia ASTELLAS PHARMA INC.,
Published by
PR Newswire
02 Apr 15 Enzalutamide Demonstrates Statistically Significant Improvement In Progression Free Survival Compared With Bicalutamide In Strive Trial ASTELLAS PHARMA INC.,
Published by
PR Newswire
25 Mar 15 ASTELLAS AND MEDIVATION ANNOUNCE NEW ENZALUTAMIDE DATA PRESENTED DURING PLENARY PRESENTATIONS AT THE 2015 EUROPEAN ASSOCIATION OF UROLOGY CONGRESS ASTELLAS, MEDIVATION,
Published by
PharmiWeb.com
23 Mar 15 2015 ASTELLAS EUROPEAN FOUNDATION FUNCTIONAL UROLOGY/URO-GYNAECOLOGY GRANT TO LOOK AT BRAIN ACTIVATION PATTERNS OF BLADDER ACTIVITY DISORDER PATIENTS Astellas European Foundation,
Published by
Astellas
19 Mar 15 New Enzalutamide Data to Be Presented in Late Breaking News Plenary Session at European Association of Urology Congress Astellas Pharma Europe Ltd. and Medivation, Inc.,
Published by
PR Newswire
09 Mar 15 Astellas Receives FDA Approval for CRESEMBA® (isavuconazonium sulfate) for the Treatment of Invasive Aspergillosis and Invasive Mucormycosis Astellas,
Published by
PharmiWeb.com
06 Mar 15 Astellas Receives FDA Approval for CRESEMBA® (isavuconazonium sulfate) for the Treatment of Invasive Aspergillosis and Invasive Mucormycosis Astellas,
Published by
Business Wire
24 Feb 15 New study indicates lower dose of Advagraf is significantly beneficial for transplant patients Astellas
24 Feb 15 DIAMOND (ADVAGRAF Studied in Combination With Mycophenolate Mofetil (MMF) and Basiliximabin Liver Transplantation) Study Provides Insights Into Kidney Function and the Prophylaxis of Organ Rejection in Liver Transplant Patients Astellas Pharma,
Published by
PR Newswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.